StageBio is delighted to announce that David Bruning is joining our team as our new CEO and President.
StageBio is delighted to announce that David Bruning is joining our team as our new CEO and President.
The StageBio team is looking forward to attending the 63nd Annual SOT Annual Meeting & Expo on March 10-14 in Salt Lake City, Utah.
In part 1 of this blog series, we reviewed key takeaways from Dr. Thomas Lemarchand’s segment in the webinar titled “Evolution of AI and Digitization in Precision Pathology and Image Analysis,” which is available to watch on demand here.
Most of us aren’t aware of the full extent in which digitization and AI technologies can impact the histopathology lab. However, over the last 25 years, we’ve seen a period of extraordinary development of digital pathology in diagnostic research and drug development.
Meet our featured StageBio pathologist, Dr. Shannon Kirejczyk (“Kir-8-sick”), DVM, MPH, PhD, DACVP, Pathologist/Principal Investigator
StageBio announces that Lori Wright, RQAP-GLP, Senior Director, Quality and Regulatory of StageBio, has been designated as the Society of Quality Assurance’s Vice President for the 2024 term.
Meet December’s featured StageBio pathologist, Dr. Tracey Papenfuss Dr. Tracey Papenfuss BS, DVM, MS, PhD (Immunology), DACVP, FIATP, Senior Pathologist/Principal Investigator, Immune Service Lead
Meet our featured StageBio pathologist, Dr. Sureshkumar Muthupalani, BVSc, MVSc, PhD, DACVP
StageBio team is hosting a webinar on “Evolution of AI and Digitization in Precision Pathology and Image Analysis” on November 10, 10amEST 2023.
The StageBio team is looking forward to sponsoring the American College of Toxicology’s annual meeting in Orlando, Florida on November 12-15 2023.